A meta-analysis of randomized trials suggests fecal microbiota transplantation can ease depressive symptoms, with stronger effects reported for endoscopic or enema delivery, according to researchers ...

Bethesda, MD (Feb. 21, 2024) — In the first comprehensive evidence-based guideline on the use of fecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological ...

After tracking biosynthetic gene clusters in 86 adults for a year, researchers found that stable gene groups predict which donor microbes persist after fecal microbiota transplantation.

A review of studies on fecal transplants alleviating symptoms of depression has found the treatment works best when the packages of helpful microbes are delivered straight to our gut through our butts ...

Scientists have identified why some gut microbes successfully stay in the gut after fecal transplants, while others are much more transient. The King's College London discovery could help make the ...

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence and ...

There was improvement in the Irritable Bowel Syndrome Impact Scale score, from 108 to 140 with fecal microbiota transplant and from 77 to 92 with placebo. HealthDay News — For patients with type 1 ...

The American Gastroenterological Association (AGA) endorsed the use of fecal microbiota-based therapies for recurrent Clostridioides difficile infections (CDIs) in new guideline recommendations, but ...

Add Yahoo as a preferred source to see more of our stories on Google. Saffron Cassaday, right, pictured with her husband and stool donor, Al Mukadam. Cassaday did fecal microbiota transplantation, ...

Fecal microbiota transplants may enhance patients’ response to immunotherapy, but experts caution that the latest data remain proof-of-concept and far from practice-changing.

A new study shows that oral fecal microbiota transplantation (FMT) is a feasible and safe addition to preventing graft-versus-host disease in patients undergoing stem cell transplantation for blood ...